Trans-regulated silencing and reactivation of TP53 tumor suppressor gene in malignant transformation and its

L Yang1, M S Sasaki

  • 1Radiation Biology Center, Kyoto University, Yoshida-Konoecho, Sakyo-ku, Kyoto 606-8501, Japan.

Insights

Tumor suppressor gene TP53 silencing in cancer is reversible, controlled by a trans-acting mechanism. Reactivation of TP53 expression was observed via chromosome transfer and demethylating agents, indicating a signaling pathway in malignancy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Methylation-mediated silencing of tumor suppressor genes is implicated in cancer, but the underlying signaling mechanisms are poorly understood.
  • The tumor suppressor gene TP53 plays a critical role in preventing cancer, and its dysregulation is common in neoplastic processes.

Purpose of the Study:

  • To investigate the signaling mechanism controlling the methylation-mediated silencing and reactivation of the tumor suppressor gene TP53.
  • To determine the role of trans-acting factors in TP53 regulation during neoplastic transformation.

Main Methods:

  • Utilized a cultured murine cell line system to study TP53 gene expression.
  • Employed X-ray irradiation to induce malignant transformation and observed changes in p53 protein levels.
  • Investigated the effect of human chromosome 11 transfer on TP53 expression.
  • Assessed the impact of the demethylating agent 5-azadeoxycytidine on TP53 reactivation.

Main Results:

  • TP53 expression, normally induced by X-ray irradiation in non-malignant cells, was undetectable in X-ray-induced malignant transformants retaining wild-type TP53.
  • Transferring a human chromosome 11 restored p53 expression in malignant cells, and these revertants became susceptible to further transformation.
  • The silent TP53 in malignant cells could be reactivated by treatment with 5-azadeoxycytidine.
  • The human chromosome 11 consistently restored TP53 expression when transferred into different malignant clones.

Conclusions:

  • A trans-acting regulatory mechanism controls the reversible silencing and reactivation of TP53 expression.
  • Methylation-mediated regulation of TP53 is associated with the acquisition of malignancy.
  • These findings elucidate a novel signaling pathway involved in tumor suppressor gene regulation and cancer development.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...